2-pyridone compounds used as inhibitors of neutrophil elastase

Details for Australian Patent Application No. 2010302420 (hide)

Owner AstraZeneca AB

Inventors Murugan, Andiappan; Ashton, Mark; Bergstrom, Lena Kristina; Kristoffersson, Anna; Lindsjo, Martin; Sjo, Peter Olof; Meigh, Jon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010302420

PCT Pub. Number WO2011/039528

Priority 61/248,081 02.10.09 US

Filing date 22 September 2010

Wipo publication date 7 April 2011

International Classifications

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4439 (2006.01)

A61K 31/497 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/039528 Priority application(s): WO2011/039528

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302425-A napkin

2010302419-Formulations for c-Met kinase inhibitors